NICE Draft Guidance Gives People Living With Hepatitis C More Treatment Options

Monday, Oct. 18th 2010 6:32 AM

NICE is currently updating part of its guidance on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. Reflecting changes in the licensed indications for peginterferon alfa, today’s draft guidance reaffirms the previous draft issued for public consultation in recommending wider use of these drugs, and, where appropriate, shorter treatment durations, for people with chronic hepatitis C.

VN:F [1.9.22_1171]
Rating: 5.0/5 (1 vote cast)
VN:F [1.9.22_1171]
Rating: 0 (from 0 votes)
NICE Draft Guidance Gives People Living With Hepatitis C More Treatment Options, 5.0 out of 5 based on 1 rating
Posted on Monday, Oct. 18th 2010 6:32 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply